Search clinical trials for: Fosaprepitant dimeglumine

Total 218 results

Philip Philip
National Cancer Institute (NCI)

Completed

Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy

Gastrointestinal Cancer | Nausea Post Chemotherapy

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

Unspecified Adult Solid Tumor, Protocol Specific | Breakthrough Nausea and Vomiting

United States
Xijing Hospital

Recruiting

Clinical on the Safety and Efficacy of Fosaprepitant Dimeglumine for Injection in the Prevention of CINV. (COSEFDIP)

Neoplasms

China
Bracco Diagnostics, Inc

Completed

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries (VALUE)

Carotid, Aortic, Renal or Peripheral Artery Disease

China
Bracco Diagnostics, Inc

Completed

Multihance at 3 Tesla (3T) in Brain Tumors

Brain Tumor

United States
Myrexis Inc.

Completed

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.

HIV Infections

Australia
University of Southern California
National Cancer Institute (NCI)

Terminated

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

Breast Cancer | Nausea | Vomiting

United States
Bracco Diagnostics, Inc

Completed

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Central Nervous System Diseases | Central Nervous System Neoplasms

United States
Bracco Diagnostics, Inc

Completed

Retrospective Study of MRI in Pediatric Patients

Central Nervous System Neoplasms | Central Nervous System Disease
Bayer

Completed

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches

Cardiovascular Abnormalities
Bracco Diagnostics, Inc

Terminated

Safety and Efficacy of MultiHance in Pediatric Patients

Central Nervous System Diseases

United States
Bayer

Completed

Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries

Renal Artery Stenosis
Bayer

Completed

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries

Stenosis
Guerbet

Completed

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions (SENTIO)

Central Nervous System Diseases | Diagnostic Self Evaluation

United States, Korea, Republic of, Argentina, Spain, France, Austria, Germany, Brazil, Chile, Italy, United Kingdom
Massachusetts General Hospital

Withdrawn

24hr Imaging Of HCC After EOVIST

Hepatocellular Carcinoma

United States
Maastricht University Medical Center

Completed

Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation

Atherosclerosis | Carotid Artery Stenosis

Netherlands
Bayer

Completed

Contrast-enhanced MRI in Children 2 Months to <2 Years

Magnetic Resonance Imaging

United States, Germany
Bayer

Completed

Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries

Peripheral Vascular Disease
Bayer

Completed

Magnevist Post-marketing Surveillance in Japan

Diagnostic Imaging

Japan
Emory University

Withdrawn

Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?

Meniere Disease

United States
Bayer

Completed

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Fibrosis | Renal Insufficiency | Kidney Failure

United States
Bayer

Completed

Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction

Myocardial Infarction

United States, Argentina
Guerbet

Completed

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Blood Brain Barrier Defect | CNS Lesion

Korea, Republic of, United States, Czechia, Italy, Belgium, Poland, Hungary, Mexico
Merck Sharp & Dohme LLC

Terminated

Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030) (EVADE)

Nausea | Vomiting
Merck Sharp & Dohme LLC

Completed

Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)

Chemotherapy-induced Nausea and Vomiting
Odense University Hospital
Helsinn Healthcare SA

Completed

Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin (GAND-emesis)

Genital Neoplasms, Female | Nausea | Vomiting

Norway, Denmark, Germany, Australia
The Affiliated Hospital of Qingdao University

Recruiting

Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation

Liver Fibrosis After Liver Transplantation | Multiparameter Magnetic Resonance Imaging

China
Merck Sharp & Dohme LLC

Terminated

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)

Chemotherapy-Induced Nausea and Vomiting
Bayer

Completed

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography

Peripheral Vascular Diseases | Peripheral Arterial Diseases | Magnetic Resonance Angiography

Japan
Donna Roberts
National Institute of Standards and Technology

Recruiting

Gadolinium Retention in Human Bone Tissue in Pediatric Patients

Magnetic Resonance Imaging | Gadolinium Retention | Gadolinium | MultiHance | Dotarem

United States
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.

Allergy

China
Northwestern University
National Cancer Institute (NCI)

Withdrawn

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Brain and Central Nervous System Tumors
Merck Sharp & Dohme LLC

Completed

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

Chemotherapy-induced Nausea and Vomiting

United States, Greece, Hungary, Lithuania, Netherlands, Peru, Poland, Russian Federation, United Kingdom
Milton S. Hershey Medical Center

Withdrawn

A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation

Shoulder Pain

United States
Bayer

Completed

Gadobutrol Magnevist-controlled Body Study

Magnetic Resonance Imaging

China, Korea, Republic of, Japan
University of Michigan

Completed

Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

Liver Tumor

United States
American College of Radiology Imaging Network
National Cancer Institute (NCI)

Completed

MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients (ACRIN 6651)

Cervical Cancer

United States
National Taiwan University Hospital

Unknown

Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis

Magnetic Resonance Imaging | Positron Emission Tomography | Breast Cancer Diagnosis

Taiwan
Dongzhimen Hospital, Beijing

Completed

Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke

Stroke | Nervous System Diseases | Ischemic Stroke | Brain Ischemia | Cerebral Infarction | Brain Infarction

China
Bayer

Completed

Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients

Vascular Diseases

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bracco Diagnostics, Inc

Completed

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. (TACE)

Hepatocellular Carcinoma

United States
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)

Chemotherapy-Induced Nausea and Vomiting (CINV)
University of Southern California
National Cancer Institute (NCI)

Terminated

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Multiple Sclerosis | Metastatic Malignant Neoplasm in the Brain | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult... and other conditions

United States
Galmed Research and Development, Ltd.
Virginia Commonwealth University

Not yet recruiting

A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis
Technical University of Munich

Completed

Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI (Gadovit)

Subacute/Chronic Myocardial Infarction

Germany
Pfizer

Completed

The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients

Transthyretin Amyloid Polyneuropathy (ATTR-PN)

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

Ischemic Stroke

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

Ischemic Stroke

China
University of Colorado, Denver
National Cancer Institute (NCI); Bracco Diagnostics, Inc

Recruiting

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

Colorectal Cancer | Liver Metastases | Oligometastatic Disease

United States
Sun Yat-sen University

Completed

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China

Search clinical trials for: Fosaprepitant dimeglumine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations